Target intelligence / Profile preview

Pathogen suppression via competitive exclusion

Molecular classification
Other
01

Overview

Pathogen suppression via competitive exclusion refers to an ecological and microbiological phenomenon where resident, beneficial, or commensal microbes prevent colonization or proliferation of pathogenic organisms by outcompeting them for resources, producing inhibitory compounds, or occupying physical niches. This process is a cornerstone of the “colonization resistance” observed in healthy microbiomes of animals and humans, and is exploited in therapeutic strategies such as fecal microbiota transplantation or probiotic administration to prevent infections like *Salmonella*, *Clostridioides difficile*, or pathogenic *E. coli*. It is not a single molecule, protein, or receptor, but rather a multifaceted community-level mechanism[1][3][9].

Other names
Competitive exclusionColonization resistanceMicrobial interferenceNiche competition
02

Mechanism of action

Nutrient competition (commensals deplete resources required by pathogens) Production of inhibitory metabolites (e.g., short-chain fatty acids, bacteriocins) Occupation of ecological niches, preventing pathogen adhesion[1][3][9] Modulation of host immune response (indirectly suppressing pathogen colonization)

03

Biological functions

Colonization resistanceMicrobial competitionSuppression of pathogen growthMaintenance of microbiome stability
04

Disease associations

Infection (bacterial, fungal, or other pathogens)Other (maintenance of host health by preventing dysbiosis)
05

Safety considerations

Risk of unintended disruptions to the resident microbiotaPotential transfer of antibiotic resistance if using live microbial productsVariable efficacy across hosts and settings
06

Interacting drugs

Probiotics (e.g., multi-strain bacterial products used in poultry or aquaculture to competitively exclude pathogens)

Beyond the preview

Go deeper on Pathogen suppression via competitive exclusion.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pathogen suppression via competitive exclusion.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call